DARLING RYAN JAMES,DICKINSON CRAIG DUANE,DRIVER DAVID ALBERT,GONCIARZ MALGORZATA DONATA,MICANOVIC RADMILA
申请号：
CO14057034
公开号：
CO6910165A2
申请日:
2014.03.17
申请国别(地区):
CO
年份:
2014
代理人:
摘要：
This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21), pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, or metabolic syndrome, or any combination thereof, using such variants.
